Found 252 matching trials
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
PHASE2Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Location
Helsinki University Hospital
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
PHASE1The purpose of this study is to test a novel dendritic cell (DC) vaccine in...
Location
Mary Crowley Medical Research Center: Baylor University Medical Center
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
PHASE1Background:
* PSA (prostate specific antigen) is a protein found on normal...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
PHASE2The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
PHASE2The main purpose of this study is to evaluate the safety of each study vacc...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells
PHASE1Background: Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stag...
Location
Instituto Médico Alexander Fleming
Vaccine Therapy in Treating Patients With Malignant Glioma
PHASE1RATIONALE: Vaccines made from peptides and a person's dendritic cells may h...
Location
Jonsson Comprehensive Cancer Center at UCLA
Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
PHASE1This phase I clinical trial is to evaluate the safety of Prodencel (an auto...
Location
Shanghai Changhai Hospital, The First Affiliated Hospital of Naval Medical University
The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
PHASE1This study aims to determine if the vacccine can be used safely in patients...